141 related articles for article (PubMed ID: 37690821)
41. Hypericin in the Light and in the Dark: Two Sides of the Same Coin.
Jendželovská Z; Jendželovský R; Kuchárová B; Fedoročko P
Front Plant Sci; 2016; 7():560. PubMed ID: 27200034
[TBL] [Abstract][Full Text] [Related]
42. Hypericin--the facts about a controversial agent.
Kubin A; Wierrani F; Burner U; Alth G; Grünberger W
Curr Pharm Des; 2005; 11(2):233-53. PubMed ID: 15638760
[TBL] [Abstract][Full Text] [Related]
43. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
44. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy.
Traynor NJ; Beattie PE; Ibbotson SH; Moseley H; Ferguson J; Woods JA
Toxicol Lett; 2005 Sep; 158(3):220-4. PubMed ID: 15890476
[TBL] [Abstract][Full Text] [Related]
45. Discovery of key regulators of dark gland development and hypericin biosynthesis in St. John's Wort (Hypericum perforatum).
Rizzo P; Altschmied L; Stark P; Rutten T; Gündel A; Scharfenberg S; Franke K; Bäumlein H; Wessjohann L; Koch M; Borisjuk L; Sharbel TF
Plant Biotechnol J; 2019 Dec; 17(12):2299-2312. PubMed ID: 31037808
[TBL] [Abstract][Full Text] [Related]
46. Substrate-dependent Inhibition of Hypericin on Human Carboxylesterase 2: Implications for Herb-drug Combination.
Wang D; Zhao T; Zhao S; Chen J; Dou T; Ge G; Wang C; Sun H; Liu K; Meng Q; Wu J
Curr Drug Metab; 2022; 23(1):38-44. PubMed ID: 35114918
[TBL] [Abstract][Full Text] [Related]
47. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
[TBL] [Abstract][Full Text] [Related]
48. Hypericin and photodynamic treatment do not interfere with transport of vitamin C during respiratory burst.
Laggner H; Schmid S; Goldenberg H
Free Radic Res; 2004 Oct; 38(10):1073-81. PubMed ID: 15512795
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment.
Butterweck V; Korte B; Winterhoff H
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S2-7. PubMed ID: 11518068
[TBL] [Abstract][Full Text] [Related]
50. Seasonal variation in hypericin content of Hypericum perforatum L. (St. John's Wort).
Southwell IA; Bourke CA
Phytochemistry; 2001 Mar; 56(5):437-41. PubMed ID: 11261576
[TBL] [Abstract][Full Text] [Related]
51. Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil.
Int J Toxicol; 2001; 20 Suppl 2():31-9. PubMed ID: 11558639
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Staffeldt B; Kerb R; Brockmöller J; Ploch M; Roots I
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S47-53. PubMed ID: 7857509
[TBL] [Abstract][Full Text] [Related]
53. Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.
Montoya A; Daza A; Muñoz D; Ríos K; Taylor V; Cedeño D; Vélez ID; Echeverri F; Robledo SM
Antimicrob Agents Chemother; 2015 Sep; 59(9):5804-13. PubMed ID: 26169411
[TBL] [Abstract][Full Text] [Related]
54. Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.
Galeotti N; Ghelardini C
Psychopharmacology (Berl); 2013 May; 227(1):149-63. PubMed ID: 23254377
[TBL] [Abstract][Full Text] [Related]
55. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
56. On the Mechanism of Action of Anti-Inflammatory Activity of Hypericin: An In Silico Study Pointing to the Relevance of Janus Kinases Inhibition.
Dellafiora L; Galaverna G; Cruciani G; Dall'Asta C; Bruni R
Molecules; 2018 Nov; 23(12):. PubMed ID: 30467287
[TBL] [Abstract][Full Text] [Related]
57. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
Dasgupta A; Hovanetz M; Olsen M; Wells A; Actor JK
Arch Pathol Lab Med; 2007 Jul; 131(7):1094-8. PubMed ID: 17616997
[TBL] [Abstract][Full Text] [Related]
58. Photophysical properties of Hypericum perforatum L. extracts--novel photosensitizers for PDT.
Skalkos D; Gioti E; Stalikas CD; Meyer H; Papazoglou TG; Filippidis G
J Photochem Photobiol B; 2006 Feb; 82(2):146-51. PubMed ID: 16388961
[TBL] [Abstract][Full Text] [Related]
59. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
[TBL] [Abstract][Full Text] [Related]
60. Phenotyping the genus Hypericum by secondary metabolite profiling: emodin vs. skyrin, two possible key intermediates in hypericin biosynthesis.
Kimáková K; Kimáková A; Idkowiak J; Stobiecki M; Rodziewicz P; Marczak Ł; Čellárová E
Anal Bioanal Chem; 2018 Nov; 410(29):7689-7699. PubMed ID: 30291388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
